Home Sectors Healthcare Long or Short: Henry Schein (NASDAQ: HSIC)

Long or Short: Henry Schein (NASDAQ: HSIC)


Henry Schein is part of the healthcare sector and is in the medical distribution industry. The company CEO is Stanley M. Bergman. Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.

Previous Intraday Trading Performance:

The HSIC stock showed a previous change of -0.96% with an open at 67.59 and a close of 67.02. It reached an intraday high of 67.81 and a low of 66.99.

SeekingAlpha:  Dental market could improve, but who knows when – Schein CFO


The stock has a market cap of $10.0b with 149.1m shares outstanding, of which the float is 147.0m shares. Trading volume reached 1,259,848 shares compared to its average volume of 1,682,440 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Henry Schein shares returned -2.15% and in the past 30 trading days it returned 8.48%. Over three months, it changed 12.02%. In one year it has changed -4.95% and within that year its 52-week high was 91.35 and its 52-week low was 56.58. HSIC stock is 18.45% above its 52 Week Low.

Our calculations show a 200 day moving average of 74.64 and a 50 day moving average of 63.26. Currently HSIC stock is trading -10.20% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

Business Wire:  Henry Schein Medical Expands Its SolutionsHub Portfolio


The last annual fiscal EPS for the company was reported at 3.49 that ended on 31st of December 2018, which according to the previous close, that is a PE of 19.20. Based on 8 analyst estimates, the consensus EPS for the next quarter is 0.76. The TTM EPS is 4.14, which comes to a TTM PE of 16.19. Historically, the PE high was 27.90 and the PE low was 16.19. HSIC stock has set a new PE low record!

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 0.73
4thQtr of 2018 0.87
3rdQtr of 2018 0.79
2ndQtr of 2018 0.92
1stQtr of 2018 0.91

Base on our calculations, the intrinsic value per share is 77.76, which means it is possibly undervalued and has a margin of safety of 13.81%.

Indicators to Watch:

The current calculated beta is 0.75.

Business Wire:  Henry Schein Medical Expands Its SolutionsHub Portfolio

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 18.58%, return on assets is 7.04%, profit margin is 4.32%, price-to-sales is 0.82 and price-to-book is 3.57.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 5  :Past Performance Score
 4  :Financial Strength Score
 1  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.